Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients

被引:88
作者
Govoni, Marcello [1 ]
Bombardieri, Stefano [2 ]
Bortoluzzi, Alessandra [1 ]
Caniatti, Luisa [3 ]
Casu, Cinzia [4 ]
Conti, Fabrizio [5 ]
de Vita, Salvatore [6 ]
Doria, Andrea [7 ]
Farina, Ilaria [1 ]
Ferraccioli, Gianfranco [8 ]
Gremese, Elisa [8 ]
Mansutti, Elisa
Mosca, Marta [2 ]
Padovan, Melissa
Piga, Matteo [9 ]
Tincani, Angela [4 ]
Tola, Maria Rosaria
Tomietto, Paola
Taglietti, Marco
Trotta, Francesco [1 ]
Valesini, Guido [5 ]
Zen, Margherita [7 ]
Mathieu, Alessandro [9 ]
机构
[1] Univ Ferrara, Dept Clin & Expt Med, Rheumatol Sect, I-44121 Ferrara, Italy
[2] Univ Pisa, Dept Internal Med, Rheumatol Unit, Pisa, Italy
[3] St Anna Hosp, Dept Neurosci, Ferrara, Italy
[4] Spedali Civili & Univ Brescia, Rheumatol & Clin Immunol Unit, Brescia, Italy
[5] Univ Roma La Sapienza, Dept Internal Med, Rome, Italy
[6] Univ Udine, Rheumatol Clin, Azienda Osped Univ S Maria Misericordia, Dept Med Subspecialties, I-33100 Udine, Italy
[7] Univ Padua, Div Rheumatol, Dept Clin & Expt Med, Padua, Italy
[8] Univ Cattolica Sacro Cuore, Div Rheumatol & Internal Med, Dept Internal Med & Med Subspecialties, CIC, I-00168 Rome, Italy
[9] Univ & AOU Cagliari, Rheumatol Unit, Cagliari, Italy
关键词
systemic lupus erythematosus; neuropsychiatric lupus; neurological involvement; anti-phospholipid antibodies; anti-phospholipid syndrome; cerebrovascular disease; CLASSIFICATION CRITERIA; CLINICAL-FEATURES; SJOGRENS-SYNDROME; DISEASE-ACTIVITY; COHORT; DAMAGE; INVOLVEMENT; MANIFESTATIONS; PREDICTORS; COLLEGE;
D O I
10.1093/rheumatology/ker310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To analyse risk factors and comorbidities potentially associated with CNS involvement in a large cohort of Italian patients affected by SLE. Methods. A number of generic (not strictly SLE related) and specific (disease related) risk factors to which all patients have been exposed in the span of 5 years before the first neuropsychiatric (NP) event or before the last available observation were checked for and their distribution was analysed in 959 SLE patients with and without NP involvement; all the first NP events that occurred in a time frame of 10 years were recorded and categorized as SLE related or SLE unrelated. Results. Three hundred and twenty-six SLE patients with and 633 SLE patients without NP manifestations were included in the study. A total of 469 NP events were recorded. Headache (26.1%), cerebrovascular events (22.7%), mood disorders (8.9%), seizures (14.4%) and cognitive dysfunctions (9.5%) were the most frequent SLE-related NP events. More risk factors [mean 4.52 (2.44) vs 3.73 (2.01); P<0.0001] were observed in patients with than without NP involvement. Overall, aPLs, LA and APS were factors more strongly associated with NP involvement. Conclusions. In SLE, NP involvement and aPLs were confirmed as closely related. Furthermore, other modifiable generic risk factors, such as hypertension, carotid vasculopathy and dyslipidaemia, appeared to be related to the occurrence of cerebral vascular accident (CVA) and cognitive dysfunctions, suggesting the need for a more intensive preventive strategy to optimize the management of NP lupus.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 49 条
[1]   Neuropsychiatric lupus syndromes -: Relationship with antiphospholipid antibodies [J].
Afeltra, A ;
Garzia, P ;
Mitterhofer, AP ;
Vadacca, M ;
Galluzzo, S ;
Del Porto, F ;
Finamore, L ;
Pascucci, S ;
Gasparini, M ;
Laganà, B ;
Caccavo, D ;
Ferri, GM ;
Amoroso, A ;
Francia, A .
NEUROLOGY, 2003, 61 (01) :108-110
[2]  
Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO
[3]  
2-X
[4]   ANTI-RO(SS-A) AUTOANTIBODIES IN CENTRAL-NERVOUS-SYSTEM DISEASE-ASSOCIATED WITH SJOGRANS SYNDROME (CNS-SS) - CLINICAL, NEUROIMAGING, AND ANGIOGRAPHIC CORRELATES [J].
ALEXANDER, EL ;
RANZENBACH, MR ;
KUMAR, AJ ;
KOZACHUK, WE ;
ROSENBAUM, AE ;
PATRONAS, N ;
HARLEY, JB ;
REICHLIN, M .
NEUROLOGY, 1994, 44 (05) :899-908
[5]   Seizures in patients with systemic lupus erythematosus:: data from LUMINA, a multiethnic cohort (LUMINA LIV) [J].
Andrade, R. M. ;
Alarcon, G. S. ;
Gonzalez, L. A. ;
Fernandez, M. ;
Apte, M. ;
Vila, L. M. ;
McGwin, G., Jr. ;
Reveille, J. D. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (06) :829-834
[6]  
[Anonymous], 1997, WHO TECHN REP SER
[7]   Epileptic seizures in systemic lupus erythematosus [J].
Appenzeller, S ;
Cendes, F ;
Costallat, LTL .
NEUROLOGY, 2004, 63 (10) :1808-1812
[8]   Mortality related to cerebrovascular disease in systemic lupus erythematosus [J].
Bernatsky, S. ;
Clarke, A. ;
Gladman, D. D. ;
Urowitz, M. ;
Fortin, P. R. ;
Barr, S. G. ;
Senecal, J-L ;
Zummer, M. ;
Edworthy, S. ;
Sibley, J. ;
Pope, J. ;
Ensworth, S. ;
Ramsey-Goldman, R. ;
Hanly, J. G. .
LUPUS, 2006, 15 (12) :835-839
[9]   Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations [J].
Bertsias, George K. ;
Boumpas, Dimitrios T. .
NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (06) :358-367
[10]  
Black HR, 1997, ARCH INTERN MED, V157, P2413